![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 39/39558 | (2013.01) | ||
A61K 31/00 | (2006.01) | ||
C07K 16/2827 | (2013.01) | ||
C07K 16/28 | (2006.01) | ||
A61K2039/505 | (2013.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 31/337 | (2013.01) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3506942 |
(13) | Kind of document | T |
(96) | European patent application number | 17778387.5 |
Date of filing the European patent application | 2017-08-31 | |
(97) | Date of publication of the European application | 2019-07-10 |
(45) | Date of publication and mention of the grant of the patent | 2022-11-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/049746 |
Date | 2017-08-31 |
(87) | Number | WO 2018/045239 |
Date | 2018-03-08 |
(30) | Number | Date | Country code |
201662382731 P | 2016-09-01 | US |
(72) |
MARKOVIC, Svetomir N. , US
NEVALA, Wendy K. , US
|
(73) |
Mayo Foundation for Medical Education and Research ,
200 First Street SW, Rochester, MN 55905,
US
|
(54) | CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS |
CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS |